Jinsong Wu, MD
Huashan Hospital · Huashan Hospital Shanghai
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jinsong Wu, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:34 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07912398 · HMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 MutationsHutchmed · not yet recruiting · Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation · principal investigator
- Ph1NCT05388487 · Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid TumorsHighField Biopharmaceuticals Corporation · unknown · Solid Tumor, Adult · principal investigator
- N/ANCT03974659 · Enhanced Recovery After Surgery Using TMS on Cerebellar Language Area for Brain Tumor PatientsHuashan Hospital · unknown · Cerebellar Function, Transcranial Magnetic Stimulation, Language Disorders · principal investigator
- N/ANCT03641391 · Awake Intraoperative Language Mapping and Chinese Probabilistic Map ConstructionHuashan Hospital · unknown · Glioma · principal investigator
- N/ANCT03152708 · CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With GlioblastomaCANbridge Life Sciences Ltd. · unknown · Glioblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioma.